|
시장보고서
상품코드
2141019
GMP 세포치료용 소모품 시장 규모, 점유율, 성장 분석 : 제품별, 세포치료 유형별, 프로세스 단계별, 최종 이용 산업별, 지역별 - 산업 예측(2026-2033년)GMP Cell Therapy Consumables Market Size, Share, and Growth Analysis, By Product (Kits, Reagents), By Cell Therapy Type, By Process Phase, By End Use Industry, By Region - Industry Forecast 2026-2033 |
||||||
세계의 GMP 세포치료용 소모품 시장 규모는 2024년에 1,505만 달러로 평가되었고, 2025년 1,940만 달러에서 2033년까지 1억 4,785만 달러로 확대되어 예측 기간(2026-2033년)에 CAGR 28.9%를 기록할 것으로 예측됩니다.
전 세계 GMP 세포 치료용 소모품 시장은 배양 배지, 스캐폴드, 동결보존제 등 임상적으로 승인된 세포 치료제 제조를 뒷받침하는 무균 및 규제 준수 제품에 대한 수요 증가가 특징입니다. 이 시장은 주로 CAR-T 치료, 줄기세포 치료, 유전자 편집 치료의 급증에 의해 주도되고 있으며, 이러한 치료법에서는 환자의 안전성과 제품의 유효성을 확보하기 위해 통제된 환경이 필수적입니다. 규제 기준이 강화됨에 따라 GMP 인증 소모품으로의 전환이 진행되고 있으며, 기업들은 이에 맞추어 생산 능력을 조정해야 할 필요에 직면해 있습니다. 또한, 동종 이계(allogeneic) 기성 제품의 부상으로 인해 확장 가능한 바이오프로세스 솔루션과 검증된 동결보존 기술이 요구되고 있으며, 이는 혁신을 더욱 촉진하고 있습니다. 제조업체들이 자체 치료 방식에서 벗어나면서 재현성과 효율성에 대한 관심이 높아지고 있으며, 이는 제품 채택 확대와 시장 전반의 성장을 뒷받침하고 있습니다.
전 세계 GMP 세포 치료용 소모품 시장의 성장 요인
다양한 치료 분야에서 세포 치료에 대한 수용도가 높아짐에 따라, 병원 및 연구 기관은 GMP 등급 소모품에 대한 투자를 확대하고 있으며, 시장에서는 안정적인 수요가 창출되고 있습니다. 임상의들은 환자 예후 개선에 있어 이러한 치료법의 잠재적 이점을 인식하고 있으며, 이는 임상시험 및 상용화 노력에 대한 참여를 촉진하고 있습니다. 이러한 임상 현장의 관심 증가는 조달 주기를 촉진하고 있으며, 제조업체들은 제품 라인업 확충과 공급망 역량 강화를 서둘러야 하는 상황에 놓여 있습니다. 그 결과, 시장은 유기적으로 계속 확대되고 있으며, 이해관계자들은 맞춤형 치료에 수반되는 복잡한 제조 공정에 필수적인, 신뢰성이 높고 고품질의 소모품 조달을 우선시하고 있습니다. 또한, 이러한 동향은 첨단 소모품의 유효성을 검증하기 위한 공동 연구를 촉진하고 있습니다.
전 세계 GMP 세포 치료용 소모품 시장의 제약 요인
전 세계 GMP 세포 치료용 소모품 시장은 제조와 관련된 종합적인 검증 및 문서화 절차를 의무화하는 엄격한 규제 체계로 인해 큰 과제에 직면해 있습니다. 이러한 엄격한 기준은 제품 개발 기간을 길게 만들며, 기업들은 끊임없이 변화하는 안전성 및 유효성 요건을 확실히 준수하기 위해 막대한 자원을 투입해야만 합니다. 지역마다 다른 규제 해석은 규정 준수 전략을 더욱 복잡하게 만들고, 투자 결정에 주저함을 초래하고 있습니다. 이러한 엄격한 요건은 시장 진입 장벽이 되어 전반적인 성장을 저해하고 있습니다. 특히 중소기업의 경우, 상용화를 성공적으로 이끌기 위해 필요한 복잡한 승인 절차를 헤쳐 나가는 데 어려움을 겪고 있어 경쟁이 극히 어려워지고 있습니다.
전 세계 GMP 세포 치료용 소모품 시장 동향
전 세계 GMP 세포 치료용 소모품 시장에서는 제조업체들이 세포 처리 키트에 실시간 분석 및 폐쇄 루프 모니터링 기능을 통합함에 따라 체험형 혁신으로의 뚜렷한 추세가 나타나고 있습니다. 이러한 발전으로 인해 임상의는 생물학적 피드백을 바탕으로 즉시 조정을 수행할 수 있게 되어, 세포 치료의 개인화 및 효능이 향상됩니다. 센서 기술과 첨단 소프트웨어를 무균 용기에 통합함으로써, 변동성을 최소화할 뿐만 아니라 환자에게 치료가 제공되기까지의 시간을 단축하여, 개인 맞춤형 치료 프로토콜에 대한 증가하는 수요에 대응하고 있습니다. 병원들이 제조 공정 전반에 걸쳐 제품의 무결성과 문서화 효율성을 최우선으로 삼는 가운데, 이러한 혁신을 도입하는 공급업체들은 가치 기반 보상 모델로의 전환이 진행 중인 시장에서 경쟁 우위를 확보할 수 있는 위치에 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 GMP 세포치료용 소모품 시장 규모 : 제품별
세계의 GMP 세포치료용 소모품 시장 규모 : 세포치료 유형별
세계의 GMP 세포치료용 소모품 시장 규모 : 프로세스 단계별
세계의 GMP 세포치료용 소모품 시장 규모 : 최종 이용 산업별
세계의 GMP 세포치료용 소모품 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.10.20Global GMP Cell Therapy Consumables Market size was valued at USD 15.05 Million in 2024 and is poised to grow from USD 19.4 Million in 2025 to USD 147.85 Million by 2033, growing at a CAGR of 28.9% during the forecast period (2026-2033).
The global GMP cell therapy consumables market is characterized by the increasing demand for sterile and compliant products that support the manufacturing of clinically approved cellular therapies, including culture media, scaffolds, and cryopreservation agents. This market is primarily driven by the surge in CAR-T, stem cell, and gene-edited therapies, which necessitate controlled environments for patient safety and product efficacy. A shift towards GMP-qualified consumables has emerged due to enhanced regulatory standards, pushing companies to adapt their production capabilities accordingly. Moreover, the rise of allogeneic off-the-shelf products calls for scalable bioprocessing solutions and validated cryopreservation technologies, further driving innovation. As manufacturers transition from autologous treatments, the focus on reproducibility and efficiency enhances product adoption and overall market growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global GMP Cell Therapy Consumables market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global GMP Cell Therapy Consumables Market Segments Analysis
Global GMP cell therapy consumables market is segmented by product, cell therapy type, process phase, end use industry and region. Based on product, the market is segmented into Kits, Reagents, Growth Factors, Interleukins and Others. Based on cell therapy type, the market is segmented into T Cell Therapy, NK Cell Therapy, Stem Cell Therapy and Others. Based on process phase, the market is segmented into Cell Collection, Characterization Sorting, Cell Culture Expansion and Others. Based on end use industry, the market is segmented into Clinical Applications, Commercial Manufacturing and Research Sector. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global GMP Cell Therapy Consumables Market
The rising acceptance of cell therapies in various therapeutic areas is prompting hospitals and research institutions to invest in GMP-grade consumables, leading to a steady demand in the market. Clinicians are acknowledging the potential benefits of these therapies in improving patient outcomes, which encourages greater participation in clinical trials and commercialization efforts. This increased clinical enthusiasm drives procurement cycles, compelling manufacturers to broaden their product offerings and strengthen their supply chain capabilities. As a result, the market continues to expand organically, with stakeholders prioritizing the acquisition of reliable, high-quality consumables essential for the intricate manufacturing processes associated with personalized treatments. Furthermore, these trends encourage collaborative research aimed at validating advanced consumables.
Restraints in the Global GMP Cell Therapy Consumables Market
The Global GMP Cell Therapy Consumables market faces significant challenges due to stringent regulatory frameworks that dictate comprehensive validation and documentation processes for manufacturing. These rigorous standards extend the product development timelines, forcing companies to dedicate considerable resources to ensure adherence to constantly evolving safety and efficacy requirements. The varying regulatory interpretations across different regions add further complexity to compliance strategies, leading to hesitancy in investment decisions. Such demanding requirements create barriers to market entry, inhibiting overall growth and making it particularly difficult for smaller firms to compete, as they struggle to navigate the intricate approval landscapes necessary for successful commercialization.
Market Trends of the Global GMP Cell Therapy Consumables Market
The Global GMP Cell Therapy Consumables market is witnessing a significant trend towards experiential innovations, as manufacturers incorporate real-time analytics and closed-loop monitoring into cell processing kits. This advancement allows clinicians to make immediate adjustments based on biological feedback, thus enhancing the customization and effectiveness of cell therapies. The integration of sensor technologies and sophisticated software into sterile containers not only minimizes variability but also expedites the time-to-patient, addressing the growing demand for personalized treatment protocols. As hospitals prioritize product integrity and streamlined documentation throughout manufacturing processes, suppliers who embrace these innovations are positioned to capture a competitive advantage in a market increasingly aligned with value-based reimbursement models.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global GMP Cell Therapy Consumables Market Size by Product & CAGR (2026-2033)
- Market Overview
- Kits
- Reagents
- Growth Factors
- Interleukins
- Others
Global GMP Cell Therapy Consumables Market Size by Cell Therapy Type & CAGR (2026-2033)
- Market Overview
- T Cell Therapy
- NK Cell Therapy
- Stem Cell Therapy
- Others
Global GMP Cell Therapy Consumables Market Size by Process Phase & CAGR (2026-2033)
- Market Overview
- Cell Collection
- Characterization Sorting
- Cell Culture Expansion
- Others
Global GMP Cell Therapy Consumables Market Size by End Use Industry & CAGR (2026-2033)
- Market Overview
- Clinical Applications
- Commercial Manufacturing
- Research Sector
Global GMP Cell Therapy Consumables Market Size & CAGR (2026-2033)
- North America (Product, Cell Therapy Type, Process Phase, End Use Industry)
- US
- Canada
- Europe (Product, Cell Therapy Type, Process Phase, End Use Industry)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product, Cell Therapy Type, Process Phase, End Use Industry)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product, Cell Therapy Type, Process Phase, End Use Industry)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product, Cell Therapy Type, Process Phase, End Use Industry)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Thermo Fisher Scientific Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cytiva
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MilliporeSigma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Group AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Corning Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Miltenyi Biotec B V & Co KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Blood and Cell Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fresenius Kabi AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Repligen Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Entegris Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Saint-Gobain Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Corning Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- STEMCELL Technologies Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PromoCell GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- FUJIFILM Irvine Scientific Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
